SlideShare a Scribd company logo
Cellular Adaptation
HNS 2201: HUMAN PATHOLOGY
Cellular Adaptations
 Adaptations are reversible changes in the number, size, phenotype, metabolic
activity, or functions of cells in response to changes in their environment.
 Physiologic adaptations usually represent responses of cells to normal
stimulation by hormones or endogenous chemical mediators (e.g., the
hormone-induced enlargement of the breast and uterus during pregnancy), or
to the demands of mechanical stress (in the case of bones and muscles).
 Pathologic adaptations are responses to stress that allow cells to modulate
their structure and function and thus escape injury, but at the expense of normal
function, such as squamous metaplasia of bronchial epithelium in smokers.
Introduction
 Cells adapt to internal environment just as the total organism adapt to external
environment
 Adaptation maybe by changes in>>
 Size
 Number
 Type
 Or
 Combination
 This leads to cellular
 Atrophy
 Hypertrophy
 Hyperplasia
 Metaplasia
 dysplasia
Atrophy
 Atrophy is shrinkage in the size of cells by the
loss of cell substance.
 When a sufficient number of cells are involved, the
entire tissue or organ is reduced in size, or atrophic .
Although atrophic cells may have diminished function,
they are not dead.
 Cellular atrophy results from a combination of
decreased protein synthesis and increased protein
degradation
Atrophy
 Atrophied cells…
 Reduce their oxygen consumption
 Other cellular functions
By….decreasing the number and size of their organelles
Causes Of Atrophy
A. Physiologic atrophy: a normal process of aging in some
tissues, which could be due to loss of:
 Endocrine stimulation
 arteriosclerosis
For example:
 Atrophy of lymphoid tissue in lymph nodes, appendix and
thymus
 Atrophy of gonads after menopause
 Atrophy of brain with aging
Causes Of Atrophy
B. Pathologic atrophy: the causes are as under:
1. Starvation atrophy: there is first depletion of
carbohydrate and fat stores followed by protein catabolism.
There is general weakness, emaciation and anemia referred to
as cachexia seen in cancer and severely ill patients
2. Ischaemic atrophy: Gradual diminution of blood
supply due to atherosclerosis may result in shrinkage of the
affected organ
e.g.
i) Small atrophic kidney in atherosclerosis of renal artery
ii) Atrophy of brain in cerebral atherosclerosis
Causes Of Atrophy
B. Pathologic atrophy Cont..
3.Disuse atrophy: Prolonged diminished functional activity is
associated with disuse atrophy of the organ
e.g.
i) Wasting of muscles of limb immobilized in cast.
ii) Atrophy of .the pancreas in obstruction of pancreatic
duct.
4. Neuropathic atrophy: Interruption in nerve supply
leads to wasting of muscles
e.g.
 i) Poliomyelitis
ii) Motor neuron disease
iii) Nerve section
Causes Of Atrophy
B. Pathologic atrophy Cont..
5. Endocrine atrophy: Loss of endocrine regulatory
mechanism results in reduced metabolic activity of tissues and
hence atrophy
e.g.
i) Hypopituitarism may lead to atrophy of thyroid, adrenal
and gonads
ii) Hypothyroidism may cause atrophy of the skin and its
adnexal structures.
Causes Of Atrophy
B. Pathologic atrophy Cont..
6. Pressure atrophy: Prolonged pressure from benign
tumors or cyst or aneurysm may cause compression and atrophy of
the tissues
e.g.
i) Erosion of spine by tumor in nerve root
ii) Erosion of skull by meningioma arising from piaarachnoid
iii) Erosion of sternum by aneurysm of arch of aorta
7. Idiopathic atrophy: There are some examples of atrophy
where no obvious cause is present
e.g.
i) Myopathies
ii) Testicular atrophy
Hypertrophy
 An increase in cell size and an increase in the functioning tissue
mass
 Stated another way, in pure hypertrophy there are no new
cells, just bigger cells containing increased amounts of
structural proteins and organelles.
 Results in an increase in tissue mass
 Seen in cardiac, skeletal, and muscle tissue
 These cells are not capable of mitosis (so, no  number or
hyperplasia)
 May be a normal physiologic response
 as seen in an increase in muscle size with exercise
 Hyperplasia is an adaptive response in cells capable of
replication, whereas hypertrophy occurs when cells have
a limited capacity to divide.
 Hypertrophy and hyperplasia also can occur together,
and obviously both result in an enlarged organ
Hypertrophy
15
hyperplasia
16
• Hypertrophy can be physiologic or pathologic and is caused either by
increased functional demand or by growth factor or hormonal
stimulation.
PHYSIOLOGIC HYPERTROPHY
1.The massive physiologic enlargement of the uterus during pregnancy occurs as a
consequence of estrogen stimulated smooth muscle hypertrophy and smooth muscle
hyperplasia
2. In contrast, in response to increased workload the striated muscle cells in both the
skeletal muscle and the heart undergo only hypertrophy because adult muscle cells have
a limited capacity to divide.
Hypertrophy
Pathologic hypertrophy
Examples:
1. Hypertrophy of cardiac muscle: may occur in:
Systemic hypertension
Aortic valve disease (stenosis and insufficiency)
Mitral insufficiency
 NB: There is an increase in size but function is compromised
 However, there is a LIMIT to the amount the tissue can
enlarge
 An adaptation to stress such as hypertrophy can progress to functionally
significant cell injury if the stress is not relieved.
 Whatever the cause of hypertrophy, a limit is reached beyond which the
enlargement of muscle mass can no longer compensate for the increased
burden.
 When this happens in the heart, several degenerative changes occur in the
myocardial fibers, of which the most important are fragmentation and loss of
myofibrillar contractile elements.
 Why hypertrophy progresses to these regressive changes is incompletely
understood. There may be finite limits on the abilities of the vasculature to
adequately supply the enlarged fibers, the mitochondria to supply ATP, or the
biosynthetic machinery to provide sufficient contractile proteins or other
cytoskeletal elements.
 The net result of these degenerative changes is ventricular dilation and
ultimately cardiac failure.
Hypertrophy
2. Compensatory hypertrophy may occur in an organ when the
contralateral organ is removed e.g.
Following nephrectomy on one side in a young patient, there
is compensatory hypertrophy as well as hyperplasia of the
nephrons of the other kidney
Adrenal hyperplasia following removal of one adrenal gland
HYPERPLASIA
 Hyperplasia is an increase in the number of parenchymal cells
resulting in enlargement of the organ or tissue
 Quite often, both hyperplasia and hypertrophy occur together
 Occurs due to a response from appropriate stimulus and ceases when
stimulus is removed
 An increase in NUMBER of cells
 Restricted to cells capable of mitosis
 epidermis, intestinal epithelium, and glandular tissue
 Physiological hyperplasia
 uterus and breast enlarge in pregnancy
Causes Of Hyperplasia
 A. Physiologic hyperplasia. The two most common types are as
follows:
1. Hormonal hyperplasia i.e. hyperplasia occurring under the
influence of hormonal stimulation e.g.
 Hyperplasia of female breast at puberty, during pregnancy and
lactation
 Hyperplasia of pregnant uterus
 Proliferative activity of normal endometrium after a normal
menstrual cycle
 Prostatic hyperplasia in old age
Causes Of Hyperplasia
2. Compensatory hyperplasia i.e. hyperplasia occurring following
removal of part of an organ or a contralateral organ in paired organ e.g.
 Regeneration of the liver following partial hepatectomy
 Regeneration of epidermis after skin abrasion
 Following nephrectomy on one side, there is hyperplasia of
nephrons of the other kidney.
Causes Of Hyperplasia
B. Pathologic hyperplasia: Most examples of pathologic hyperplasia are
due to excessive stimulation of hormones or growth factors e.g.
Endometrial hyperplasia following estrogen excess
In wound healing, there is formation of granulation tissue due to
proliferation of fibroblasts and endothelial cells
Formation of skin warts from hyperplasia of epidermis due to
human papilloma virus
Pseudocarcinomatous hyperplasia of the skin
Intraductal epithelial hyperplasia in the breast in fibrocystic
breast disease.
prostatic hypertrophy (BPH or thyroid enlargement
 Nevertheless,in many cases, pathologic hyperplasia constitutes a fertile soil in
which cancers may eventually arise.
 For example, patients with hyperplasia of the endometrium are at increased
risk of developing endometrial cancer
METAPLASIA
 Metaplasia is a change in which one adult cell type (epithelial or mesenchymal) is
replaced by another adult cell type.
 In this type of cellular adaptation, a cell type sensitive to a particular stress is replaced by
another cell type better able to withstand the adverse environment.
 Metaplasia is thought to arise by the reprogramming of stem cells to differentiate along a new
pathway rather than a phenotypic change (transdifferentiation) of already differentiated cells
 Epithelial metaplasia is exemplified by the change that occurs in the respiratory epithelium of
habitual cigarette smokers, in whom the normal ciliated columnar epithelial cells of the trachea
and bronchi often are replaced by stratified squamous epithelial cells
 The rugged stratified squamous epithelium may be able to survive the noxious chemicals in
cigarette smoke that the more fragile specialized epithelium would not tolerate.
 Metaplasia: change in phenotype of differentiated cells, often in response to chronic irritation,
that makes cells better able to withstand the stress; usually induced by altered differentiation
pathway of tissue stem cells; may result in reduced functions or increased propensity/tendancy
for malignant transformation
 Although the metaplastic squamous epithelium has survival advantages,
important protective mechanisms are lost, such as mucus secretion and ciliary
clearance of particulate matter.
 Because vitamin A is essential for normal epithelial differentiation, its deficiency
also may induce squamous metaplasia in the respiratory epithelium.
 Metaplasia need not always occur in the direction of columnar to squamous
epithelium; in chronic gastric reflux, the normal stratified squamous epithelium
of the lower esophagus may undergo metaplastic transformation to gastric or
intestinal-type columnar epithelium.
 Metaplasia also may occur in mesenchymal cells, but in these situations it is
generally a reaction to some pathologic alteration and not an adaptive response
to stress. For example, bone is occasionally formed in soft tissues, particularly
in foci of injury.
 The influences that induce metaplastic change in an epithelium, if
persistent, may predispose to malignant transformation.
 In fact, squamous metaplasia of the respiratory epithelium often coexists with
lung cancers composed of malignant squamous cells.
 It is thought that cigarette smoking initially causes squamous metaplasia, and
cancers arise later in some of these altered foci
DYSPLASIA
 Dysplasia means ‘disordered cellular development’, often
accompanied with metaplasia and hyperplasia; it is therefore also
referred to as atypical hyperplasia
 Dysplasia occurs most often in epithelial cells
 Epithelial dysplasia is characterized by:
cellular proliferation
cytologic changes.
 Dysplastic changes often occur due to:
chronic irritation
prolonged inflammation
DYSPLASIA
 On removal of the inciting stimulus, the changes may disappear
 In a proportion of cases, however, dysplasia progresses into:
 carcinoma in situ (cancer confined to layers superficial to
basement membrane)
or
invasive cancer
 The Dysplasia Changes include:
Increased number of layers of epithelial cells
Disorderly arrangement of cells from basal layer to the
surface layer
DYSPLASIA
Loss of basal polarity i.e. nuclei lying away from basement
membrane
Cellular and nuclear pleomorphism
Increased nucleocytoplasmic ratio
Nuclear hyperchromatism
Increased mitotic activity
Differences between Metaplasia and Dysplasia
Metaplasia
 Change of one type of epithelial
or mesenchymalcell to another
type of adult epithelial or
mesenchymal cell
 Epithelial (squamous, columnar)
and mesenchymal (osseous,
cartilaginous)
 Most commonly affects bronchial
mucosa, uterine endocervix;
others mesenchymal tissues
(cartilage, arteries)
Dysplasia
 Disordered cellular development,
may beaccompanied with
hyperplasia or metaplasia
 Epithelial only
 Uterine cervix, bronchial mucosa
Differences between Metaplasia and Dysplasia
Metaplasia
 Mature cellular
development
 Reversible on withdrawal of
stimulus
Dysplasia
 Disordered cellular development
(pleomorphism,nuclear
hyperchromasia, mitosis, loss of
polarity)
 May regress on removal of inciting
stimulus, or may progress to higher
grades of dysplasia or carcinoma in
situ
Anaplasia
 Cells differentiate to a more IMMATURE or embryonic form.
 Malignant tumors are characterized by anaplastic cell growth.
Summary: Cellular Changes

More Related Content

What's hot

lecture 9-GRANULOMATOUS INFLAMMATION .ppt
lecture 9-GRANULOMATOUS INFLAMMATION .pptlecture 9-GRANULOMATOUS INFLAMMATION .ppt
lecture 9-GRANULOMATOUS INFLAMMATION .ppt
MohammadFaisal565026
 
Lect.2
Lect.2Lect.2
chronic inflammation
chronic inflammationchronic inflammation
chronic inflammation
Government Medical College
 
Pathology Final Practical
Pathology Final PracticalPathology Final Practical
Pathology Final Practical
MD Specialclass
 
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.pptLESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
mdaquib14
 
Cellular responses to stress and noxious stimuli
Cellular responses to stress and noxious stimuliCellular responses to stress and noxious stimuli
Cellular responses to stress and noxious stimuli
Aj Cocjin
 
Cell injury. intracellular extracellular accumulation
Cell injury. intracellular extracellular accumulationCell injury. intracellular extracellular accumulation
Cell injury. intracellular extracellular accumulation
Ganapathy Tamilselvan
 
Chronic inflammation
Chronic inflammation Chronic inflammation
Chronic inflammation
Mohammad Manzoor
 
General pathology lecture
General pathology lectureGeneral pathology lecture
General pathology lecture
Dr Vincent Musungu
 
Cell Adaptation
Cell AdaptationCell Adaptation
Cell Adaptation
Suraj Choudhary
 
6 cell injury2
6 cell injury26 cell injury2
6 cell injury2
Lama K Banna
 
Pathology Lecture - Neoplasia
Pathology Lecture - NeoplasiaPathology Lecture - Neoplasia
Pathology Lecture - Neoplasia
Shashidhar Venkatesh Murthy
 
Healing and repair specialized tissue- 3
Healing and repair   specialized tissue- 3Healing and repair   specialized tissue- 3
Healing and repair specialized tissue- 3
dinesh
 
Neoplasia 1
Neoplasia 1 Neoplasia 1
Cell injury and hypertrophy
Cell injury and hypertrophyCell injury and hypertrophy
Cell injury and hypertrophy
Zainab&Sons
 
Ch 2 adaptations, cell injury, cell death
Ch 2 adaptations, cell injury, cell deathCh 2 adaptations, cell injury, cell death
Ch 2 adaptations, cell injury, cell death
Ashish Jawarkar
 
Pathology of immune system
Pathology of immune systemPathology of immune system
Pathology of immune system
Ganapathy Tamilselvan
 
Hyperplasia
HyperplasiaHyperplasia
Hyperplasia
Noman-Hafeez khosa
 
Healing and repair
Healing and repair Healing and repair
Healing and repair
dinesh
 
Chronic inflammation 5 10-2016
Chronic inflammation 5 10-2016Chronic inflammation 5 10-2016
Chronic inflammation 5 10-2016
pathologydept
 

What's hot (20)

lecture 9-GRANULOMATOUS INFLAMMATION .ppt
lecture 9-GRANULOMATOUS INFLAMMATION .pptlecture 9-GRANULOMATOUS INFLAMMATION .ppt
lecture 9-GRANULOMATOUS INFLAMMATION .ppt
 
Lect.2
Lect.2Lect.2
Lect.2
 
chronic inflammation
chronic inflammationchronic inflammation
chronic inflammation
 
Pathology Final Practical
Pathology Final PracticalPathology Final Practical
Pathology Final Practical
 
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.pptLESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
 
Cellular responses to stress and noxious stimuli
Cellular responses to stress and noxious stimuliCellular responses to stress and noxious stimuli
Cellular responses to stress and noxious stimuli
 
Cell injury. intracellular extracellular accumulation
Cell injury. intracellular extracellular accumulationCell injury. intracellular extracellular accumulation
Cell injury. intracellular extracellular accumulation
 
Chronic inflammation
Chronic inflammation Chronic inflammation
Chronic inflammation
 
General pathology lecture
General pathology lectureGeneral pathology lecture
General pathology lecture
 
Cell Adaptation
Cell AdaptationCell Adaptation
Cell Adaptation
 
6 cell injury2
6 cell injury26 cell injury2
6 cell injury2
 
Pathology Lecture - Neoplasia
Pathology Lecture - NeoplasiaPathology Lecture - Neoplasia
Pathology Lecture - Neoplasia
 
Healing and repair specialized tissue- 3
Healing and repair   specialized tissue- 3Healing and repair   specialized tissue- 3
Healing and repair specialized tissue- 3
 
Neoplasia 1
Neoplasia 1 Neoplasia 1
Neoplasia 1
 
Cell injury and hypertrophy
Cell injury and hypertrophyCell injury and hypertrophy
Cell injury and hypertrophy
 
Ch 2 adaptations, cell injury, cell death
Ch 2 adaptations, cell injury, cell deathCh 2 adaptations, cell injury, cell death
Ch 2 adaptations, cell injury, cell death
 
Pathology of immune system
Pathology of immune systemPathology of immune system
Pathology of immune system
 
Hyperplasia
HyperplasiaHyperplasia
Hyperplasia
 
Healing and repair
Healing and repair Healing and repair
Healing and repair
 
Chronic inflammation 5 10-2016
Chronic inflammation 5 10-2016Chronic inflammation 5 10-2016
Chronic inflammation 5 10-2016
 

Similar to Cellular Adaptation.pptx

Cellular_adaptation_dr_AMAL_D_&_T_DR_AMAL_2023_lecture.pdf
Cellular_adaptation_dr_AMAL_D_&_T_DR_AMAL_2023_lecture.pdfCellular_adaptation_dr_AMAL_D_&_T_DR_AMAL_2023_lecture.pdf
Cellular_adaptation_dr_AMAL_D_&_T_DR_AMAL_2023_lecture.pdf
waadswaid
 
D. Lamyaa Cell Injury-1 (Muhadharaty).pptx
D. Lamyaa Cell Injury-1 (Muhadharaty).pptxD. Lamyaa Cell Injury-1 (Muhadharaty).pptx
D. Lamyaa Cell Injury-1 (Muhadharaty).pptx
muhammedsayfadin
 
celladaptation-190708165026.pdf
celladaptation-190708165026.pdfcelladaptation-190708165026.pdf
celladaptation-190708165026.pdf
GaurishChandraRathau
 
Cellular or Cell adaptation !! pathology - Harsh mohan !! cell injury
Cellular or Cell adaptation !! pathology - Harsh mohan !! cell injuryCellular or Cell adaptation !! pathology - Harsh mohan !! cell injury
Cellular or Cell adaptation !! pathology - Harsh mohan !! cell injury
Dr. S N Medical College, Jodhpur
 
Cell adaptation.by drmunir hussain hmc pico
Cell adaptation.by drmunir hussain hmc picoCell adaptation.by drmunir hussain hmc pico
Cell adaptation.by drmunir hussain hmc pico
ABIDOFFICIALCHANNEL
 
3 Cell adaptation by Ashiq wazir
3 Cell adaptation by Ashiq wazir3 Cell adaptation by Ashiq wazir
3 Cell adaptation by Ashiq wazir
AshiqWazir
 
Cellular adaptations by NOM KUMAR NAIK
Cellular adaptations by NOM KUMAR NAIKCellular adaptations by NOM KUMAR NAIK
Cellular adaptations by NOM KUMAR NAIK
NOM KUMAR NAIK BHUKYA
 
cell adaptation or cellular adaptation-190708165026.pptx
cell adaptation or cellular adaptation-190708165026.pptxcell adaptation or cellular adaptation-190708165026.pptx
cell adaptation or cellular adaptation-190708165026.pptx
siddhimeena3
 
Cell injury l1 medical sept 2018
Cell injury l1 medical sept 2018Cell injury l1 medical sept 2018
Cell injury l1 medical sept 2018
Sufia Husain
 
CELL ADAPTATON_091737.pptx
CELL ADAPTATON_091737.pptxCELL ADAPTATON_091737.pptx
CELL ADAPTATON_091737.pptx
OutaRobert1
 
Cell Adaptation, physiology and pathology....pdf
Cell Adaptation, physiology and pathology....pdfCell Adaptation, physiology and pathology....pdf
Cell Adaptation, physiology and pathology....pdf
siddhimeena3
 
Growth disturbances
Growth disturbancesGrowth disturbances
Growth disturbances
Nityanand Upadhyay
 
Introduction to pathology.pptx
Introduction to pathology.pptxIntroduction to pathology.pptx
Introduction to pathology.pptx
Yomif3
 
Puviyarasi MSC Nursing,PATHOLOGY UNIT-1.pptx
Puviyarasi MSC Nursing,PATHOLOGY UNIT-1.pptxPuviyarasi MSC Nursing,PATHOLOGY UNIT-1.pptx
Puviyarasi MSC Nursing,PATHOLOGY UNIT-1.pptx
Puviyarasi1
 
cellular adaptation presentation (2)
cellular adaptation presentation    (2)cellular adaptation presentation    (2)
cellular adaptation presentation (2)
HamnazBeegumpp
 
2- Pathology CELL INJURY L1 Medical Sept 2020.ppt
2- Pathology CELL INJURY L1 Medical Sept 2020.ppt2- Pathology CELL INJURY L1 Medical Sept 2020.ppt
2- Pathology CELL INJURY L1 Medical Sept 2020.ppt
Shady151977
 
2- Pathology CELL INJURY L1 Medical Sept 2020.ppt
2- Pathology CELL INJURY L1 Medical Sept 2020.ppt2- Pathology CELL INJURY L1 Medical Sept 2020.ppt
2- Pathology CELL INJURY L1 Medical Sept 2020.ppt
Abdelrhman Abooda
 
cellinjuryadaptationanddeathfix-120702045317-phpapp01.ppt
cellinjuryadaptationanddeathfix-120702045317-phpapp01.pptcellinjuryadaptationanddeathfix-120702045317-phpapp01.ppt
cellinjuryadaptationanddeathfix-120702045317-phpapp01.ppt
JaanuJaanu20
 
Basic principles of cell injury and adaptation
Basic principles of cell injury and adaptationBasic principles of cell injury and adaptation
Basic principles of cell injury and adaptation
shivangimistry3
 
Adaptation of cellular growth & differentiation
Adaptation of cellular growth & differentiationAdaptation of cellular growth & differentiation
Adaptation of cellular growth & differentiation
Hrudi Sahoo
 

Similar to Cellular Adaptation.pptx (20)

Cellular_adaptation_dr_AMAL_D_&_T_DR_AMAL_2023_lecture.pdf
Cellular_adaptation_dr_AMAL_D_&_T_DR_AMAL_2023_lecture.pdfCellular_adaptation_dr_AMAL_D_&_T_DR_AMAL_2023_lecture.pdf
Cellular_adaptation_dr_AMAL_D_&_T_DR_AMAL_2023_lecture.pdf
 
D. Lamyaa Cell Injury-1 (Muhadharaty).pptx
D. Lamyaa Cell Injury-1 (Muhadharaty).pptxD. Lamyaa Cell Injury-1 (Muhadharaty).pptx
D. Lamyaa Cell Injury-1 (Muhadharaty).pptx
 
celladaptation-190708165026.pdf
celladaptation-190708165026.pdfcelladaptation-190708165026.pdf
celladaptation-190708165026.pdf
 
Cellular or Cell adaptation !! pathology - Harsh mohan !! cell injury
Cellular or Cell adaptation !! pathology - Harsh mohan !! cell injuryCellular or Cell adaptation !! pathology - Harsh mohan !! cell injury
Cellular or Cell adaptation !! pathology - Harsh mohan !! cell injury
 
Cell adaptation.by drmunir hussain hmc pico
Cell adaptation.by drmunir hussain hmc picoCell adaptation.by drmunir hussain hmc pico
Cell adaptation.by drmunir hussain hmc pico
 
3 Cell adaptation by Ashiq wazir
3 Cell adaptation by Ashiq wazir3 Cell adaptation by Ashiq wazir
3 Cell adaptation by Ashiq wazir
 
Cellular adaptations by NOM KUMAR NAIK
Cellular adaptations by NOM KUMAR NAIKCellular adaptations by NOM KUMAR NAIK
Cellular adaptations by NOM KUMAR NAIK
 
cell adaptation or cellular adaptation-190708165026.pptx
cell adaptation or cellular adaptation-190708165026.pptxcell adaptation or cellular adaptation-190708165026.pptx
cell adaptation or cellular adaptation-190708165026.pptx
 
Cell injury l1 medical sept 2018
Cell injury l1 medical sept 2018Cell injury l1 medical sept 2018
Cell injury l1 medical sept 2018
 
CELL ADAPTATON_091737.pptx
CELL ADAPTATON_091737.pptxCELL ADAPTATON_091737.pptx
CELL ADAPTATON_091737.pptx
 
Cell Adaptation, physiology and pathology....pdf
Cell Adaptation, physiology and pathology....pdfCell Adaptation, physiology and pathology....pdf
Cell Adaptation, physiology and pathology....pdf
 
Growth disturbances
Growth disturbancesGrowth disturbances
Growth disturbances
 
Introduction to pathology.pptx
Introduction to pathology.pptxIntroduction to pathology.pptx
Introduction to pathology.pptx
 
Puviyarasi MSC Nursing,PATHOLOGY UNIT-1.pptx
Puviyarasi MSC Nursing,PATHOLOGY UNIT-1.pptxPuviyarasi MSC Nursing,PATHOLOGY UNIT-1.pptx
Puviyarasi MSC Nursing,PATHOLOGY UNIT-1.pptx
 
cellular adaptation presentation (2)
cellular adaptation presentation    (2)cellular adaptation presentation    (2)
cellular adaptation presentation (2)
 
2- Pathology CELL INJURY L1 Medical Sept 2020.ppt
2- Pathology CELL INJURY L1 Medical Sept 2020.ppt2- Pathology CELL INJURY L1 Medical Sept 2020.ppt
2- Pathology CELL INJURY L1 Medical Sept 2020.ppt
 
2- Pathology CELL INJURY L1 Medical Sept 2020.ppt
2- Pathology CELL INJURY L1 Medical Sept 2020.ppt2- Pathology CELL INJURY L1 Medical Sept 2020.ppt
2- Pathology CELL INJURY L1 Medical Sept 2020.ppt
 
cellinjuryadaptationanddeathfix-120702045317-phpapp01.ppt
cellinjuryadaptationanddeathfix-120702045317-phpapp01.pptcellinjuryadaptationanddeathfix-120702045317-phpapp01.ppt
cellinjuryadaptationanddeathfix-120702045317-phpapp01.ppt
 
Basic principles of cell injury and adaptation
Basic principles of cell injury and adaptationBasic principles of cell injury and adaptation
Basic principles of cell injury and adaptation
 
Adaptation of cellular growth & differentiation
Adaptation of cellular growth & differentiationAdaptation of cellular growth & differentiation
Adaptation of cellular growth & differentiation
 

More from AMOSKIPNGETICH

LECTURE 2 SIGNS AND SYMPTOMS.pdf
LECTURE 2 SIGNS AND SYMPTOMS.pdfLECTURE 2 SIGNS AND SYMPTOMS.pdf
LECTURE 2 SIGNS AND SYMPTOMS.pdf
AMOSKIPNGETICH
 
shock-190119202315.pdf
shock-190119202315.pdfshock-190119202315.pdf
shock-190119202315.pdf
AMOSKIPNGETICH
 
Anti-infective agents3.ppt
Anti-infective agents3.pptAnti-infective agents3.ppt
Anti-infective agents3.ppt
AMOSKIPNGETICH
 
ACUTE INFLAMMATION.pptx
ACUTE INFLAMMATION.pptxACUTE INFLAMMATION.pptx
ACUTE INFLAMMATION.pptx
AMOSKIPNGETICH
 
Anti-fective agents4.ppt
Anti-fective agents4.pptAnti-fective agents4.ppt
Anti-fective agents4.ppt
AMOSKIPNGETICH
 
GENDER AND HUMAN SEXUALITY UPDATED.pptx
GENDER AND HUMAN SEXUALITY UPDATED.pptxGENDER AND HUMAN SEXUALITY UPDATED.pptx
GENDER AND HUMAN SEXUALITY UPDATED.pptx
AMOSKIPNGETICH
 

More from AMOSKIPNGETICH (6)

LECTURE 2 SIGNS AND SYMPTOMS.pdf
LECTURE 2 SIGNS AND SYMPTOMS.pdfLECTURE 2 SIGNS AND SYMPTOMS.pdf
LECTURE 2 SIGNS AND SYMPTOMS.pdf
 
shock-190119202315.pdf
shock-190119202315.pdfshock-190119202315.pdf
shock-190119202315.pdf
 
Anti-infective agents3.ppt
Anti-infective agents3.pptAnti-infective agents3.ppt
Anti-infective agents3.ppt
 
ACUTE INFLAMMATION.pptx
ACUTE INFLAMMATION.pptxACUTE INFLAMMATION.pptx
ACUTE INFLAMMATION.pptx
 
Anti-fective agents4.ppt
Anti-fective agents4.pptAnti-fective agents4.ppt
Anti-fective agents4.ppt
 
GENDER AND HUMAN SEXUALITY UPDATED.pptx
GENDER AND HUMAN SEXUALITY UPDATED.pptxGENDER AND HUMAN SEXUALITY UPDATED.pptx
GENDER AND HUMAN SEXUALITY UPDATED.pptx
 

Recently uploaded

Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 

Cellular Adaptation.pptx

  • 2. Cellular Adaptations  Adaptations are reversible changes in the number, size, phenotype, metabolic activity, or functions of cells in response to changes in their environment.  Physiologic adaptations usually represent responses of cells to normal stimulation by hormones or endogenous chemical mediators (e.g., the hormone-induced enlargement of the breast and uterus during pregnancy), or to the demands of mechanical stress (in the case of bones and muscles).  Pathologic adaptations are responses to stress that allow cells to modulate their structure and function and thus escape injury, but at the expense of normal function, such as squamous metaplasia of bronchial epithelium in smokers.
  • 3. Introduction  Cells adapt to internal environment just as the total organism adapt to external environment  Adaptation maybe by changes in>>  Size  Number  Type  Or  Combination  This leads to cellular  Atrophy  Hypertrophy  Hyperplasia  Metaplasia  dysplasia
  • 4. Atrophy  Atrophy is shrinkage in the size of cells by the loss of cell substance.  When a sufficient number of cells are involved, the entire tissue or organ is reduced in size, or atrophic . Although atrophic cells may have diminished function, they are not dead.  Cellular atrophy results from a combination of decreased protein synthesis and increased protein degradation
  • 5.
  • 6.
  • 7. Atrophy  Atrophied cells…  Reduce their oxygen consumption  Other cellular functions By….decreasing the number and size of their organelles
  • 8. Causes Of Atrophy A. Physiologic atrophy: a normal process of aging in some tissues, which could be due to loss of:  Endocrine stimulation  arteriosclerosis For example:  Atrophy of lymphoid tissue in lymph nodes, appendix and thymus  Atrophy of gonads after menopause  Atrophy of brain with aging
  • 9. Causes Of Atrophy B. Pathologic atrophy: the causes are as under: 1. Starvation atrophy: there is first depletion of carbohydrate and fat stores followed by protein catabolism. There is general weakness, emaciation and anemia referred to as cachexia seen in cancer and severely ill patients 2. Ischaemic atrophy: Gradual diminution of blood supply due to atherosclerosis may result in shrinkage of the affected organ e.g. i) Small atrophic kidney in atherosclerosis of renal artery ii) Atrophy of brain in cerebral atherosclerosis
  • 10. Causes Of Atrophy B. Pathologic atrophy Cont.. 3.Disuse atrophy: Prolonged diminished functional activity is associated with disuse atrophy of the organ e.g. i) Wasting of muscles of limb immobilized in cast. ii) Atrophy of .the pancreas in obstruction of pancreatic duct. 4. Neuropathic atrophy: Interruption in nerve supply leads to wasting of muscles e.g.  i) Poliomyelitis ii) Motor neuron disease iii) Nerve section
  • 11. Causes Of Atrophy B. Pathologic atrophy Cont.. 5. Endocrine atrophy: Loss of endocrine regulatory mechanism results in reduced metabolic activity of tissues and hence atrophy e.g. i) Hypopituitarism may lead to atrophy of thyroid, adrenal and gonads ii) Hypothyroidism may cause atrophy of the skin and its adnexal structures.
  • 12. Causes Of Atrophy B. Pathologic atrophy Cont.. 6. Pressure atrophy: Prolonged pressure from benign tumors or cyst or aneurysm may cause compression and atrophy of the tissues e.g. i) Erosion of spine by tumor in nerve root ii) Erosion of skull by meningioma arising from piaarachnoid iii) Erosion of sternum by aneurysm of arch of aorta 7. Idiopathic atrophy: There are some examples of atrophy where no obvious cause is present e.g. i) Myopathies ii) Testicular atrophy
  • 13. Hypertrophy  An increase in cell size and an increase in the functioning tissue mass  Stated another way, in pure hypertrophy there are no new cells, just bigger cells containing increased amounts of structural proteins and organelles.  Results in an increase in tissue mass  Seen in cardiac, skeletal, and muscle tissue  These cells are not capable of mitosis (so, no  number or hyperplasia)  May be a normal physiologic response  as seen in an increase in muscle size with exercise
  • 14.  Hyperplasia is an adaptive response in cells capable of replication, whereas hypertrophy occurs when cells have a limited capacity to divide.  Hypertrophy and hyperplasia also can occur together, and obviously both result in an enlarged organ
  • 17. • Hypertrophy can be physiologic or pathologic and is caused either by increased functional demand or by growth factor or hormonal stimulation. PHYSIOLOGIC HYPERTROPHY 1.The massive physiologic enlargement of the uterus during pregnancy occurs as a consequence of estrogen stimulated smooth muscle hypertrophy and smooth muscle hyperplasia 2. In contrast, in response to increased workload the striated muscle cells in both the skeletal muscle and the heart undergo only hypertrophy because adult muscle cells have a limited capacity to divide.
  • 18. Hypertrophy Pathologic hypertrophy Examples: 1. Hypertrophy of cardiac muscle: may occur in: Systemic hypertension Aortic valve disease (stenosis and insufficiency) Mitral insufficiency  NB: There is an increase in size but function is compromised  However, there is a LIMIT to the amount the tissue can enlarge
  • 19.  An adaptation to stress such as hypertrophy can progress to functionally significant cell injury if the stress is not relieved.  Whatever the cause of hypertrophy, a limit is reached beyond which the enlargement of muscle mass can no longer compensate for the increased burden.  When this happens in the heart, several degenerative changes occur in the myocardial fibers, of which the most important are fragmentation and loss of myofibrillar contractile elements.  Why hypertrophy progresses to these regressive changes is incompletely understood. There may be finite limits on the abilities of the vasculature to adequately supply the enlarged fibers, the mitochondria to supply ATP, or the biosynthetic machinery to provide sufficient contractile proteins or other cytoskeletal elements.  The net result of these degenerative changes is ventricular dilation and ultimately cardiac failure.
  • 20. Hypertrophy 2. Compensatory hypertrophy may occur in an organ when the contralateral organ is removed e.g. Following nephrectomy on one side in a young patient, there is compensatory hypertrophy as well as hyperplasia of the nephrons of the other kidney Adrenal hyperplasia following removal of one adrenal gland
  • 21. HYPERPLASIA  Hyperplasia is an increase in the number of parenchymal cells resulting in enlargement of the organ or tissue  Quite often, both hyperplasia and hypertrophy occur together  Occurs due to a response from appropriate stimulus and ceases when stimulus is removed  An increase in NUMBER of cells  Restricted to cells capable of mitosis  epidermis, intestinal epithelium, and glandular tissue  Physiological hyperplasia  uterus and breast enlarge in pregnancy
  • 22. Causes Of Hyperplasia  A. Physiologic hyperplasia. The two most common types are as follows: 1. Hormonal hyperplasia i.e. hyperplasia occurring under the influence of hormonal stimulation e.g.  Hyperplasia of female breast at puberty, during pregnancy and lactation  Hyperplasia of pregnant uterus  Proliferative activity of normal endometrium after a normal menstrual cycle  Prostatic hyperplasia in old age
  • 23. Causes Of Hyperplasia 2. Compensatory hyperplasia i.e. hyperplasia occurring following removal of part of an organ or a contralateral organ in paired organ e.g.  Regeneration of the liver following partial hepatectomy  Regeneration of epidermis after skin abrasion  Following nephrectomy on one side, there is hyperplasia of nephrons of the other kidney.
  • 24. Causes Of Hyperplasia B. Pathologic hyperplasia: Most examples of pathologic hyperplasia are due to excessive stimulation of hormones or growth factors e.g. Endometrial hyperplasia following estrogen excess In wound healing, there is formation of granulation tissue due to proliferation of fibroblasts and endothelial cells Formation of skin warts from hyperplasia of epidermis due to human papilloma virus Pseudocarcinomatous hyperplasia of the skin Intraductal epithelial hyperplasia in the breast in fibrocystic breast disease. prostatic hypertrophy (BPH or thyroid enlargement
  • 25.  Nevertheless,in many cases, pathologic hyperplasia constitutes a fertile soil in which cancers may eventually arise.  For example, patients with hyperplasia of the endometrium are at increased risk of developing endometrial cancer
  • 26. METAPLASIA  Metaplasia is a change in which one adult cell type (epithelial or mesenchymal) is replaced by another adult cell type.  In this type of cellular adaptation, a cell type sensitive to a particular stress is replaced by another cell type better able to withstand the adverse environment.  Metaplasia is thought to arise by the reprogramming of stem cells to differentiate along a new pathway rather than a phenotypic change (transdifferentiation) of already differentiated cells  Epithelial metaplasia is exemplified by the change that occurs in the respiratory epithelium of habitual cigarette smokers, in whom the normal ciliated columnar epithelial cells of the trachea and bronchi often are replaced by stratified squamous epithelial cells  The rugged stratified squamous epithelium may be able to survive the noxious chemicals in cigarette smoke that the more fragile specialized epithelium would not tolerate.  Metaplasia: change in phenotype of differentiated cells, often in response to chronic irritation, that makes cells better able to withstand the stress; usually induced by altered differentiation pathway of tissue stem cells; may result in reduced functions or increased propensity/tendancy for malignant transformation
  • 27.  Although the metaplastic squamous epithelium has survival advantages, important protective mechanisms are lost, such as mucus secretion and ciliary clearance of particulate matter.  Because vitamin A is essential for normal epithelial differentiation, its deficiency also may induce squamous metaplasia in the respiratory epithelium.  Metaplasia need not always occur in the direction of columnar to squamous epithelium; in chronic gastric reflux, the normal stratified squamous epithelium of the lower esophagus may undergo metaplastic transformation to gastric or intestinal-type columnar epithelium.  Metaplasia also may occur in mesenchymal cells, but in these situations it is generally a reaction to some pathologic alteration and not an adaptive response to stress. For example, bone is occasionally formed in soft tissues, particularly in foci of injury.  The influences that induce metaplastic change in an epithelium, if persistent, may predispose to malignant transformation.
  • 28.  In fact, squamous metaplasia of the respiratory epithelium often coexists with lung cancers composed of malignant squamous cells.  It is thought that cigarette smoking initially causes squamous metaplasia, and cancers arise later in some of these altered foci
  • 29. DYSPLASIA  Dysplasia means ‘disordered cellular development’, often accompanied with metaplasia and hyperplasia; it is therefore also referred to as atypical hyperplasia  Dysplasia occurs most often in epithelial cells  Epithelial dysplasia is characterized by: cellular proliferation cytologic changes.  Dysplastic changes often occur due to: chronic irritation prolonged inflammation
  • 30. DYSPLASIA  On removal of the inciting stimulus, the changes may disappear  In a proportion of cases, however, dysplasia progresses into:  carcinoma in situ (cancer confined to layers superficial to basement membrane) or invasive cancer  The Dysplasia Changes include: Increased number of layers of epithelial cells Disorderly arrangement of cells from basal layer to the surface layer
  • 31. DYSPLASIA Loss of basal polarity i.e. nuclei lying away from basement membrane Cellular and nuclear pleomorphism Increased nucleocytoplasmic ratio Nuclear hyperchromatism Increased mitotic activity
  • 32.
  • 33. Differences between Metaplasia and Dysplasia Metaplasia  Change of one type of epithelial or mesenchymalcell to another type of adult epithelial or mesenchymal cell  Epithelial (squamous, columnar) and mesenchymal (osseous, cartilaginous)  Most commonly affects bronchial mucosa, uterine endocervix; others mesenchymal tissues (cartilage, arteries) Dysplasia  Disordered cellular development, may beaccompanied with hyperplasia or metaplasia  Epithelial only  Uterine cervix, bronchial mucosa
  • 34. Differences between Metaplasia and Dysplasia Metaplasia  Mature cellular development  Reversible on withdrawal of stimulus Dysplasia  Disordered cellular development (pleomorphism,nuclear hyperchromasia, mitosis, loss of polarity)  May regress on removal of inciting stimulus, or may progress to higher grades of dysplasia or carcinoma in situ
  • 35. Anaplasia  Cells differentiate to a more IMMATURE or embryonic form.  Malignant tumors are characterized by anaplastic cell growth.